{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:39:32Z","timestamp":1761061172744,"version":"3.37.3"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Vasoplegia has been reported in patients receiving angiotensin receptor-neprilysin inhibitors (ARNI) with heart failure with reduced ejection fraction (HFrEF). We present a case of vasoplegic shock after initiation of ARNI in a hospitalized 65-year-old man recovering from cardiogenic shock (CS) and acute kidney injury (AKI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 65-year-old man with HFrEF presented to a community hospital with CS with evidence of poor perfusion with a lactate of 5.6\u2009mmol\/L and creatinine (Cr) 125 \u00b5mol\/L. He was treated with intravenous furosemide infusion. Subsequently, his lactate normalized but he developed an AKI with a Cr of 176 \u00b5mol\/L. He was then started on ARNI and beta blockers. Over the next 24\u2009h, he developed a vasoplegic shock necessitating multiple vasopressors and a transfer to a tertiary academic centre. With supportive therapy, his vasoplegic shock improved and he was discharged home.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>PARADIGM-HF found that the introduction of an ARNI in patients with ambulatory symptomatic HFrEF reduces the risk of death and heart failure hospitalization. Most recently, PIONEER-HF showed that ARNI reduced N-terminal pro-B-type natriuretic peptide levels at 4 and 8\u2009weeks, without significantly different rates of medication-related adverse effects. However, thus far, no clinical trials have examined the role of ARNI in CS. Our case report highlights the risk of vasoplegic shock caused by initiation of ARNI in patients hospitalized with CS especially in whom renal and hepatic impairment is present.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaa233","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T15:15:26Z","timestamp":1603120526000},"page":"1-4","source":"Crossref","is-referenced-by-count":6,"title":["Crossing the chasm: caution for use of angiotensin receptor-neprilysin inhibition in patients with cardiogenic shock\u2013 a case report"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5838-7397","authenticated-orcid":false,"given":"Loai","family":"Almazroa","sequence":"first","affiliation":[{"name":"Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, 18-365 600 University Avenue, Toronto, ON M5G 1X5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Mihajlovic","sequence":"additional","affiliation":[{"name":"Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, 18-365 600 University Avenue, Toronto, ON M5G 1X5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick R.","family":"Lawler","sequence":"additional","affiliation":[{"name":"Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, 18-365 600 University Avenue, Toronto, ON M5G 1X5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3042-4210","authenticated-orcid":false,"given":"Adriana","family":"Luk","sequence":"additional","affiliation":[{"name":"Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, 18-365 600 University Avenue, Toronto, ON M5G 1X5, Canada"},{"name":"Division of Cardiology, Sinai Health System\/University Health Network, 18-365 600 University Avenue, Toronto, ON M5G 1X5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"2021010812210524100_ytaa233-B1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cjca.2017.08.022","article-title":"2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"2021010812210524100_ytaa233-B2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2021010812210524100_ytaa233-B3","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"2021010812210524100_ytaa233-B4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2021010812210524100_ytaa233-B5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"key":"2021010812210524100_ytaa233-B6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/CIRCULATIONAHA.110.981720","article-title":"Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats","volume":"123","author":"Cataliotti","year":"2011","journal-title":"Circulation"},{"key":"2021010812210524100_ytaa233-B7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/01.CIR.0000105726.89770.35","article-title":"Chronic infusion of bradykinin delays the progression of heart failure and preserves vascular endothelium-mediated vasodilation in conscious dogs","volume":"109","author":"Tonduangu","year":"2004","journal-title":"Circulation"},{"key":"2021010812210524100_ytaa233-B8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/01.CIR.0000136085.34185.83","article-title":"Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats","volume":"110","author":"Nakamura","year":"2004","journal-title":"Circulation"},{"key":"2021010812210524100_ytaa233-B9","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.118.039331","article-title":"Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril\/valsartan or enalapril in the PIONEER-HF trial","volume":"139","author":"Morrow","year":"2019","journal-title":"Circulation"},{"key":"2021010812210524100_ytaa233-B10","doi-asserted-by":"crossref","first-page":"343.e5","DOI":"10.1016\/j.cjca.2017.12.004","article-title":"Profound vasoplegia during sacubitril\/valsartan treatment after heart transplantation","volume":"34","author":"Almufleh","year":"2018","journal-title":"Can J Cardiol"},{"year":"2017","key":"2021010812210524100_ytaa233-B11"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/4\/6\/1\/35544526\/ytaa233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcr\/article-pdf\/4\/6\/1\/35544526\/ytaa233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T23:51:46Z","timestamp":1610581906000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/4\/6\/1\/5930397"}},"subtitle":[],"editor":[{"given":"Domenico","family":"D'Amario","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Richard","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Lilit","family":"Baghdasaryan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Vamvakidou","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":11,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,10,19]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaa233","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,10,19]]}}}